Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02135900 · ClinicalTrials.gov registry record · Phase 2
The Use of Heliox in Obstructive Sleep Apnea Syndrome
A Phase 2 study of Obstructive Sleep Apnea Syndrome, sponsored by Northwell Health.
- Completed
- Registry status
- Phase 2
- Development phase
- 32
- Enrollment target
- 1
- Study location
NCT02135900: Completed Phase 2 study of Obstructive Sleep Apnea Syndrome, sponsored by Northwell Health.
NCT02135900 is a Phase 2 study of Obstructive Sleep Apnea Syndrome that has completed, run by Northwell Health. The registered enrollment target is 32 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02135900, a Phase 2 study of Obstructive Sleep Apnea Syndrome, has completed, sponsored by Northwell Health.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 32 participants
- Enrollment target
- 1
- Study location
Study Summary
The goals of the project is to evaluate the effects of Heliox therapy on obstructive sleep apnea syndrome (OSAS).
Primary Outcome
Assessment of Apnea/Hypopnea Index (AHI) at baseline ( without heliox) and after 6-8 hours of sleep with heliox.
Conditions Studied
Interventions
- DRUG Heliox
Study Locations (1)
New York
- Sleep center, Staten Island University Hospital - Staten Island
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2009-12 |
| Est. Completion | 2011-04 |
| Phase | Phase 2 |
What the finished NCT02135900 record still lists
NCT02135900 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (76% lower).
The record links to 1 condition, with Obstructive Sleep Apnea Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Heliox is the first listed.
NCT02135900 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT02135900 about?
NCT02135900 is a clinical study titled "The Use of Heliox in Obstructive Sleep Apnea Syndrome". The goals of the project is to evaluate the effects of Heliox therapy on obstructive sleep apnea syndrome (OSAS).
What is the current status of trial NCT02135900?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 32 participants. The study started on 2009-12. Estimated completion is 2011-04.
What conditions does trial NCT02135900 study?
This clinical trial studies the following conditions: Obstructive Sleep Apnea Syndrome.
What interventions are being tested in trial NCT02135900?
The interventions under investigation include: Heliox (DRUG).
Who is sponsoring clinical trial NCT02135900?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02135900 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obstructive Sleep Apnea Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02135900's enrollment target sits among peer trials
32 1563rd of 2000 higher than 423 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia